Day: January 31, 2023

Acronis signs on as a gold sponsor for the communications and digital transformation event of the year

FORT LAUDERDALE, Fla., Jan. 31, 2023 (GLOBE NEWSWIRE) — Acronis, a global leader in cyber protection, announced today that it will be a gold sponsor at the MSP EXPO, held February 14-17, 2023 at the Broward County Convention Center in Fort Lauderdale, Florida. Collocated with ITEXPO, #TECHSUPERSHOW MSP EXPO is The Premier Conference and Networking Summit for MSPs – where MSP business owners and technology specialists share strategies to grow their managed services businesses.

Meet Acronis at MSP EXPO booth 735 to learn more about the company’s unified data protection and cybersecurity solutions which deliver integrated, automated cyber protection that solves the safety, accessibility, privacy, authenticity, and security (SAPAS) challenges of the modern digital world. There will be a very special guest appearance by NFL sports legend and former Miami Dolphins running back, Ronnie Brown, at Acronis booth 735 on Thursday, February 16 from 3:00 – 5:00 pm ET. Be sure to stop by to get your signed autograph!

In addition to Acronis’ representation as a gold sponsor for the event, the company’s ISV Technical Evangelist, James Abercrombie, will take part in two informative panel discussions. The first, taking place on Tuesday, February 14 at 1:30 pm ET in room 303B will take a deep dive into Securing Microsoft365 Environments. In this session, attendees will learn what Microsoft’s security solutions can do, what they can’t, and how MSPs can help their customers understand whether they need third-party security solutions to fill gaps. The other panel discussion, taking place on Wednesday, February 15 at 10:30 am ET in room 303B will explore New Opportunities in Cloud Storage. This session will discuss business storage needs, different cloud storage options and new models, and how MSPs can benefit from the ever-increasing need for storage and backup services.

For more than 20 years, executives, technology buyers, sellers, resellers, and manufacturers from companies of all sizes and industries assemble at ITEXPO to forge new business partnerships, collaborate and learn together and from one another. Dozens of conference sessions, keynotes, and panels will be focused on helping attendees move their businesses forward.

“Acronis is ecstatic to be the Gold Sponsor of the 2023 MSP Expo,” said Florence Jule, Senior Director of Global Partner Programs at Acronis. “2023 marks a monumental year as the 20th anniversary of Acronis. We invite all MSP Expo attendees to visit booth 735 to learn our integrated cyber protection solution that reduces complexity with a single-agent platform. As a channel-focused organization, MSPs are the heart of our business. We pride ourselves on providing a robust partner program that help MSPs grow and provides all the training and marketing tools necessary to reach their profit goals. As we celebrate two decades of innovation, we’re excited to network and discover how we can further partner together to grow our businesses in the IT channel.”

Registration for MSP EXPO is now open. Use code “Acronis25”, or the following link, for 25% off #TECHSUPERSHOW All Access Superpass: https://www.tmcnet.com/scripts/events/registration.aspx?theplan=ITMSP0223-AS&sc=Acronis25

For more information on sessions and panels, or to view the full agenda, visit: https://www.mspexpo.com/east/agenda.aspx

For the latest MSP EXPO news, updates and information follow the event on Twitter at @MSPEXPO.

About Acronis
Acronis unifies data protection and cybersecurity to deliver integrated, automated cyber protection that solves the safety, accessibility, privacy, authenticity, and security (SAPAS) challenges of the modern digital world. With flexible deployment models that fit the demands of service providers and IT professionals, Acronis provides superior cyber protection for data, applications, and systems with innovative next-generation antivirus, backup, disaster recovery, and endpoint protection management solutions powered by AI. With advanced anti-malware powered by cutting-edge machine intelligence and blockchain based data authentication technologies, Acronis protects any environment – from cloud to hybrid to on premises – at a low and predictable cost.

Acronis is a Swiss company, founded in Singapore. Celebrating two decades of innovation, Acronis has more than 2,000 employees in 45 locations. Acronis Cyber Protect solution is available in 26 languages in over 150 countries and is used by 16,000 service providers to protect over 750,000 businesses.

About TMC
Through education, industry news, live events and social influence, global buyers rely on TMC’s content-driven marketplaces to make purchase decisions and navigate markets. As a result, leading technology vendors turn to TMC for unparalleled branding, thought leadership and lead generation opportunities. Our in-person and online events deliver unmatched visibility and sales prospects for all participants. Through our custom lead generation programs, we provide clients with an ongoing stream of leads that turn into sales opportunities and build databases. Additionally, we bolster brand reputations with the millions of impressions from display advertising on our news sites and newsletters. Making TMC a 360-degree marketing solution, we offer comprehensive event and road show management services and custom content creation with expertly ghost-crafted blogs, press releases, articles and marketing collateral to help with SEO, branding, and overall marketing efforts. For more information about TMC and to learn how we can help you reach your marketing goals, please visit www.tmcnet.com and follow us on Facebook, LinkedIn and Twitter @tmcnet.

Media and Analyst Contact:
Michelle Connolly
Senior Marketing Manager
203.852.6800 ext.170
rconnolly@tmcnet.com

Acronis Contact:
Karl Bateson
Director of Global Communications
karl.bateson@acronis.com

GlobeNewswire Distribution ID 8739444

Newest enhancements to InEight’s construction project management platform bring better forecasting accuracy, improved field collaboration, and more visibility and control over subcontractor performance.

SCOTTSDALE, Ariz., Jan. 31, 2023 (GLOBE NEWSWIRE) — InEight Inc., a global leader in construction capital project management software, has announced its latest suite of software innovations, which are designed to increase forecasting accuracy, field productivity, and subcontractor management.

These latest updates provide contractors with a higher level of forecasting accuracy based on up-to-date project progress, including subcontractor activity. This allows for quick reactions to financial and productivity challenges, providing greater confidence to project owners.

Uncertain economic conditions and disruptions in the construction supply chain are putting increased pressure on contractors and owner/operators to produce accurate project forecasts. InEight is building on its already strong legacy in cost forecasting with significant new capabilities in the areas of time-phased forecasting, custom forecasting methods, and resource-based forecasts.

In addition to out-of-the-box forecast methods, InEight users can now configure the best equations to automate forecast calculations for the different types of work through different stages of completion. “There is no one-size-fits-all approach when it comes to forecasting, even within a single project,” says John Upton, Director Project Cost Management at InEight. “InEight helps contractors and owners better capture field data and measure progress,”

The platform enhancements also drive increased productivity through more efficient collaboration between the office and the field. Scope and quantities, productivity goals, and more are easily communicated in daily digital plans to field crews and subcontractors. Controlled transparency allows teams to identify and troubleshoot challenges. This leads to a higher level of profitability potential.

Additionally, InEight made it easier to get full visibility into subcontractor costs. With line of sight to both committed and uncommitted costs, users can compare the variance between the planned cost and the actual costs.

“Our goal is to connect scope, cost, and schedule on a single platform, giving project stakeholders the ability to collaborate effectively and deliver projects with predictable results,” comments Brad Barth, Chief Product Officer at InEight.

About InEight

InEight provides field-tested project management software for the owners, contractors, engineers and designers who are building the world around us. Over 575,000 users and more than 850 customers worldwide rely on InEight for real-time insights that help manage risk and keep projects on schedule and under budget across the entire life cycle.

From pre-planning to design, from estimating to scheduling, and from field execution to turnover, InEight has powered more than $1 trillion in projects globally across infrastructure, public sector, energy and power, oil, gas and chemical, mining, and commercial. For more information, follow InEight on LinkedIn or visit InEight.com.

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

Media Contact:

Linda Coy, Global Marketing Director, InEight press@ineight.com

GlobeNewswire Distribution ID 8739155

Next-generation SaaS technology will enable study sponsors and CROs to better design, plan, and monitor clinical trials, from feasibility to start-up through enrollment

NEW YORK, Jan. 31, 2023 (GLOBE NEWSWIRE) — At the Summit for Clinical Ops Executives (SCOPE) Feb. 6-9 in Orlando, Citeline will reveal details of its soon-to-be-released clinical feasibility workflow solution. The new technology leverages insights from Citeline’s industry-leading clinical trial benchmark data and real-world patient data with AI/ML technology to improve accuracy and predictability in progressively complex and accelerated clinical trial programs.

“Citeline is on an exciting transformational journey as a data intelligence and predictive clinical trial workflow solution provider,” said Alexandra Charge, Global Head of Clinical Planning and Patient Engagement & Recruitment. “The feasibility and clinical trial recruitment challenge is complex and ever present. Modernizing feasibility with AI and data science, unlocking the power of client data together with Citeline’s trusted industry-leading intelligence and real-world data, all enabled within a smart workflow, is key to addressing these complexities.”

The next-generation solution will help study leaders address ever-increasing complexity in enrollment projections, ensure success in selecting high-enrolling sites to accelerate timelines, and quickly identify and mitigate risks. It incorporates insights from Citeline’s industry-leading clinical trial benchmark data, real-world patient data and AI/ML technology within an intuitive user workflow interface to improve efficiency and accuracy of recruitment plans. Key attributes are used to determine overall trial success, from modern feasibility planning to study recruitment.

“Citeline’s new predictive enrollment modeling technology enables data-driven decisions and earlier identification of risks, ultimately leading to better trial success,” Charge said.

SCOPE attendees can learn more at the following Citeline sessions:

• Human-enabled AI with Interactive Real-world Data and Technology, Feb. 7 at 2:45 p.m.: an interactive panel of AI and pharma experts will discuss using modern feasibility tools to reduce future risk
• Transforming Patient Engagement & Recruitment for Lean Clinical Trials, Feb. 8 at 12:50 p.m.: a strategy-focused session, in partnership with Incyte, on what it takes to operationalize a seamless, trustworthy clinical trial experience

Attendees can visit the Citeline booth or talk to any of Citeline’s experts attending SCOPE to learn how Citeline can help with the ever-growing complexity of feasibility and forecasting — whether per study, portfolio or across the entire enterprise. Citeline’s anticipated next-generation predictive technology solution is scheduled for launch later this year. However, the Feasibility as a Service (FaaS) consultation solutions have already been launched to address the challenges of protocol, country and site feasibility.

Citeline’s FaaS blends historical trial data with RWD-driven capabilities to accelerate, enhance and better inform global clinical research feasibility activities. Combined with actionable insights derived from an internal team of industry expert analysts, Citeline provides a comprehensive, consultative approach to study feasibility.

About Citeline
Citeline (formerly Pharma Intelligence) powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory-related decisions and create real-world opportunities for growth.

Citeline’s global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. For more information on one of the world’s most trusted health science partners, visit Citeline.

Citeline PR contact:
Diffusion PR for Pharma Intelligence
citeline@diffusionpr.com
(213) 318-4500

GlobeNewswire Distribution ID 8738883

Enables Geospatially Accurate 3D Simulations with Digital Twins

MONTREAL, Jan. 31, 2023 (GLOBE NEWSWIRE) — Presagis, developer of the VELOCITY 5D (V5D) digital twin production platform, today announced availability of the V5D Plugin for Unreal Engine, the most powerful 3D computer graphics engine on the market today. The plugin enables users to load a GIS-generated V5D digital twin into Unreal Engine to create highly realistic visualizations and simulations of entire cities and even countries.

“The primary application of the Unreal Engine Plugin will be in 3D visualization applications covering large geographic areas because of V5D’s unmatched ability to produce 3D digital twins from massive geospatial data sets,” said Jean-Michel Briere, Presagis President.

The most beneficial applications of the plugin will be in aviation, aerospace, urban planning, disaster preparation, and defense simulations that need to include expansive geographies. Visualizations that span long linear distances, such as the design of transportation routes and utility corridors, will also benefit. V5D for Unreal is the perfect extension of the scalable and highly automated, cloud based CDB production pipeline VELOCITY 5D. V5D for Unreal allow users to create custom visualization and simulation experiences in Unreal Engine while natively loading OGC CDB content produced by Velocity 5D platform or other OGC CDB compliant toolsets.

Release of the plugin is a win-win for existing users of both V5D and Unreal Engine, Briere explained. V5D users will be able to make powerful 3D fly-throughs and immersive simulations of their GIS-based digital twins. Unreal Engine users can now incorporate geospatially accurate cityscapes and terrains into their 3D experiences.

Launched in November 2022 by Presagis, V5D is a cloud-based platform that quickly and automatically converts massive volumes of geospatial data into high-fidelity 3D digital twins. With no geospatial processing expertise, V5D users can easily produce accurate digital twins from multiple 2D data sets, including GIS vector layers, remote sensing imagery, and other structured and unstructured data of any size, format, or type.

Developed by Epic Games, Unreal Engine is the 3D computer graphics generator that powers many of the world’s most popular and successful video games. Due to its vivid graphics and extremely accurate spatial presentation capabilities, Unreal Engine is increasingly being employed in other industries using 3D visualization and simulation technologies for improved understanding of current or future situations, risks and conditions.

Presagis will demonstrate the Unreal Engine plugin along with the unmatched speed, scalability, and realism of the V5D platform in booth #340 at GeoWeek 2023 being held February 13-15 in Denver, Colorado.

To learn more about the V5D Unreal Engine Plugin, please visit: https://www.presagis.com/en/product/v5d-unreal/.

About Presagis:

PRESAGIS is a global leader providing advanced 3D modeling and simulation, and embedded software solutions to the aerospace, defense, security, critical infrastructure, and GIS markets. PRESAGIS combines an open simulation development framework with expert professional services to help customers build vast dynamic virtual environments, deliver game-quality immersive simulations – all the while streamlining workflows and reducing risks. PRESAGIS recently launched cloud-based VELOCITY 5D platform quickly and automatically converts massive volumes of 2D geospatial data into high-fidelity 3D digital twins. V5D leverages artificial intelligence and game engine technology to run complex visualization and simulation scenarios that derive context from the digital twins. PRESAGIS is also at the forefront of avionics software design for certifiable cockpit displays, and, together with its 3D modeling and simulation offerings, serves hundreds of customers worldwide, including many of the world’s most respected organizations such as Boeing, Lockheed Martin, Airbus, BAE Systems, and CAE. For more information, visit www.presagis.com.

Media Contact:
Carlos Carpio, Director of Marketing and Communications: +1 514.222.0593
carlos.carpio@presagis.com

GlobeNewswire Distribution ID 8739215

PHOENIX, Jan. 31, 2023 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC) today announced it will release its fourth quarter 2022 financial results on Tuesday, February 21, 2023, after market close.

Chief Executive Officer Brad Soultz and President and Chief Financial Officer Tim Boswell will host a conference call and webcast on Wednesday, February 22, 2023, at 10 a.m. ET to discuss the results.

To access the live call by phone, use the following link: https://register.vevent.com/register/BI8f94abaee57f4f2ea09de369cf8b804a. You will be provided with dial-in details after registering. To avoid delays, we recommend that participants dial into the conference call 15 minutes ahead of the scheduled start time. A live webcast will also be accessible via the “Events & Presentations” section of the Company’s website www.willscotmobilemini.com. An archived version of the webcast will be available for 12 months following the call.

About WillScot Mobile Mini

WillScot Mobile Mini trades on the Nasdaq stock exchange under the ticker symbol “WSC.” Headquartered in Phoenix, Arizona, the Company is a leading business services provider specializing in innovative flexible workspace and portable storage solutions. WillScot Mobile Mini services diverse end markets across all sectors of the economy from a network of approximately 240 branch locations and additional drop lots throughout the United States, Canada, and Mexico.

Additional Information and Where to Find It

Additional information can be found on the company’s website at www.willscotmobilemini.com

Media Contact Information

Jake Saylor

jake.saylor@willscot.com

Investor Contact Information

Nick Girardi

nick.girardi@willscotmobilemini.com

GlobeNewswire Distribution ID 8739358

New York-based credit union to implement Nexus Engagement, Nexus Origination and Nexus Closing to modernize the member homebuying experience and gain process efficiencies

LEHI, Utah, Jan. 31, 2023 (GLOBE NEWSWIRE) — SimpleNexus (https://simplenexus.com/), an nCino (NASDAQ: NCNO) company and developer of the leading U.S. homeownership platform for loan officers, borrowers, real estate agents and settlement agents, announced today that AmeriCU will implement Nexus Engagement, Nexus Origination and Nexus Closing to provide a streamlined, mobile-first member experience.

Founded in 1950, AmeriCU is a member-owned, not-for-profit financial institution with more than 150,000 members and $2.4 billion in assets. AmeriCU’s mortgage loan originators help members achieve their financial goals by connecting them with conventional fixed-rate mortgages, adjustable-rate mortgages, jumbo loans, Veterans Administration (VA) loans, home equity loans, home equity lines of credit (HELOCs) and more.

“At AmeriCU, the satisfaction of our members is always our number one priority,” said Stephanie McGuire, senior vice president of lending at AmeriCU. “By equipping our mortgage teams with intelligent tools from SimpleNexus, they will be able to offer our members a more holistic homebuying experience and achieve unprecedented operational efficiency.”

Nexus Engagement helps lenders engage pre-application leads and strengthen referral strategies with real estate agents via a shareable mobile app featuring integrated tools such as homesearch listings and a payment calculator. Nexus Origination, SimpleNexus’ point-of-sale (POS) technology, enables borrowers to apply for a loan, submit documents, monitor loan status, contact their loan officer, electronically sign (eSign) disclosures and more. Nexus Closing is a comprehensive solution that supports traditional, hybrid and fully digital eClosings. Leveraging these tools together will enable AmeriCU to offer members a modern, single-sign-on experience via a mobile app while benefiting from the productivity advantages of streamlined workflows.

To maximize the process efficiencies of SimpleNexus, AmeriCU will activate SimpleNexus’ native integration with the credit union’s new loan origination system (LOS). Bi-directional data syncing between SimpleNexus and AmeriCU’s LOS will enable originators to enjoy simplified workflows. For instance, loan officers will have the ability to quickly generate and send disclosure documents directly from the SimpleNexus mobile app.

“SimpleNexus is a cost-effective resource for credit unions that want to offer members a more convenient and connected homebuying experience,” said Ben Miller, CEO of SimpleNexus. “Our mobile toolset, made stronger by native integrations and an open API framework, facilitates a state-of-the-art homebuying experience from point-of-thought to close.”

About SimpleNexus
SimpleNexus, an nCino (NASDAQ: NCNO) company, is an award-winning developer of mobile-first technology for the modern mortgage lender. U.S. lenders depend on our namesake homeownership platform to unite the people, systems and stages of the mortgage process into a seamless, end-to-end solution that spans engagement, origination, closing and business intelligence. By helping lenders manage their teams and stay connected with borrowers and real estate professionals, we deliver a measurable return on investment in the form of reduced turn times, increased loan application submissions and more referral business. A four-time Inc. 5000 company, SimpleNexus has been recognized as one of the world’s Best Workplaces for Innovators. For more information, visit https://www.simplenexus.com or follow @SimpleNexus.

About AmeriCU

As a credit union, AmeriCU is a not-for-profit financial institution owned by our members. Serving nine counties in Central and Northern New York, AmeriCU provides you with all the products and services you need – often with low or no fees, and better rates. The organization has been serving the local community for over 70 years and, in that time, has grown to more than 160,000 members, 20 locations, and $2.4 billion in assets. AmeriCU is located in Central New York and is among the State’s largest, full-service financial cooperatives. For more information, visit https://www.americu.org/.

Media Contacts
Leslie Colley
DepthPR for SimpleNexus
+1 678.622.6229
leslie@depthpr.com

David Bolin
SimpleNexus
+1 414.688.6077
dbolin@simplenexus.com

Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally include actions, events, results, strategies and expectations and are often identifiable by use of the words “believes,” “expects,” “intends,” “anticipates,” “plans,” “seeks,” “estimates,” “projects,” “may,” “will,” “could,” “might,” or “continues” or similar expressions. Any forward-looking statements contained in this press release are based upon nCino’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent nCino’s expectations as of the date of this press release. Subsequent events may cause these expectations to change and, except as may be required by law, nCino does not undertake any obligation to update or revise these forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially including, among others, risks and uncertainties relating to the market adoption of our solution and privacy and data security matters. Additional risks and uncertainties that could affect nCino’s business and financial results are included in reports filed by nCino with the U.S. Securities and Exchange Commission (available on our web site at www.ncino.com or the SEC’s web site at www.sec.gov). Further information on potential risks that could affect actual results will be included in other filings nCino makes with the SEC from time to time.

GlobeNewswire Distribution ID 8739424

The approval allows Eyenuk’s AI eye screening system, already approved for detection of diabetic retinopathy, to aid millions of additional patients at risk for vision loss

LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) — Eyenuk, a global artificial intelligence (AI) digital health company, and the leader in real-world applications for AI Eye Screening and AI Predictive Biomarkers, has been approved to market its EyeArt® AI eye screening system in the European Union for the new uses of detecting age-related macular degeneration (AMD) and glaucomatous optic nerve damage (a sign of glaucoma).

The EyeArt AI system (version 3.0) has been granted a new European Commission (EC) certification as a Class IIb medical device under the EU’s Medical Devices Regulation 2017/745 (“MDR”) and is intended to detect signs of diabetic retinopathy (DR) (including diabetic macular edema), AMD, and glaucomatous optic nerve damage in patients at risk of vision loss using computerized analysis of images of the retina. The EyeArt AI system was previously approved in the EU for the detection of DR including diabetic macular edema.

This EC Certification makes the EyeArt AI system the first and only autonomous AI solution with Class IIb MDR CE marking for the automated detection of all three eye diseases and will allow Eyenuk customers in the EU to detect the diseases in a single exam using the same set of retinal images. The EyeArt AI system is also the first and only system that is both CE Marked for the detection of the three diseases as well as FDA-cleared in the United States for the detection of DR, the leading cause of blindness among working-age adults.

The EyeArt AI system greatly expands the availability of vision-saving eye screenings by making automated AI diagnosis and coordination of care possible in primary care medical practices without the need for a specialist’s review. The system is integrated with retinal imaging cameras and can be operated by clinical support staff to generate a detailed screening report in less than 30 seconds. In regions with limited access to ophthalmologists, its ability to detect multiple eye diseases with a single exam can help reduce vision loss from these blinding eye diseases.

Malavika Bhaskaranand, Head of Regulatory and Clinical Affairs at Eyenuk, commented, “Achieving MDR certification is a major milestone for Eyenuk and a result of our early adaptation to the more stringent requirements of the new regulation. It reaffirms the strong results from rigorous clinical validation of the EyeArt AI system.”

Kaushal Solanki, Chief Executive Officer and Founder of Eyenuk, commented, “This EC certification multiplies our impact in two ways. First, our autonomous AI can now help many more patients at risk of vision loss – the population at risk of AMD and glaucoma, particularly seniors, in addition to people with diabetes. Second, our AI system can now provide a more comprehensive report for each patient with detection results for three diseases compared to just one previously.”

Solanki continued, “DR, AMD, and glaucoma are all asymptomatic in their early stages. The high sensitivity of the EyeArt AI system, and its ability to be delivered without a specialist, makes it easier to catch the diseases early and to take preventative measures to protect the vision of these patients. We look forward to the opportunity to forge new partnerships with world-class hospitals and healthcare institutions in Europe to help preserve the eyesight of millions across the continent with these diseases.”

EC Certification Caps Year of Breakthroughs for Eyenuk

The EC Certification of the EyeArt AI system caps a year of significant clinical and business milestones for Eyenuk. The company’s accomplishments in 2022 included:

• Securing $26 million in a Series A financing round, bringing the company’s total funding to over $43 million
• Reaching the new milestone of 70,000 patients screened using the EyeArt AI system globally since its FDA clearance in August 2020, by far the most screenings by any FDA-cleared autonomous AI system
• Growing the number of locations using the EyeArt AI system to more than 200 in 18 countries and throughout the US
• Publication of a major peer-reviewed study finding that the EyeArt AI system is far more sensitive in identifying referable DR than dilated eye exams by ophthalmologists and retina specialists
• Winning Juniper Research’s Future Digital Health award for the “Best Digital Diagnostics Solution”
• Being named a finalist for the UCSF Digital Health Award

About Eyenuk, Inc.

Eyenuk, Inc. is a global artificial intelligence (AI) digital health company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers for risk assessment and disease surveillance. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk, and Alzheimer’s disease. Find Eyenuk online on its website, Twitter, Facebook, and LinkedIn.

About the EyeArt AI System

The EyeArt AI system provides fully autonomous screening for diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucomatous optic nerve damage, including retinal imaging, based on international clinical standards and immediate reporting, in a single office visit during a patient’s regular exam. Once the patient’s fundus images have been captured and submitted to the EyeArt AI System, the detection results are available in a PDF report in less than 30 seconds.

The EyeArt AI system was developed with funding from the U.S. National Institutes of Health and is validated by the U.K. National Health Service. The EyeArt AI system has CE marking as a class IIb medical device in the European Union under the EU’s Medical Devices Regulation 2017/745 (“MDR”) for the detection of DR, AMD, and glaucomatous optic nerve damage. Additionally, the system has U.S. Food and Drug Administration 510(k) clearance and a Health Canada license for autonomous detection of DR. It is designed to be General Data Protection Regulation (GDPR) and Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.

The EyeArt AI system is reimbursable by government and private payors in the U.S. under the Category 1 Current Procedural Terminology (CPT) code 92229.

Learn more about the EyeArt AI System by watching this video.

Media Inquiries:
Todd Stein
510-417-0612
Todd@toddsteincommunications.com

GlobeNewswire Distribution ID 8739343